Daily Schedule - Sunday - September 28

Concurrent Sessions 1-2
10:00 a.m.-11:45 a.m.

Concurrent Session 1: Computational Science: Leveraging Computer Data for Large Data Sets
Session Chairperson: Yu Shyr, Vanderbilt-Ingram Cancer Center, Nashville, Tenn.

Big challenges of big data: Biomedical science in the petabyte era
Yu Shyr

Instrumenting the healthcare enterprise for discovery research
Shawn N. Murphy, Massachusetts General Hospital, Boston, Mass.

Risk stratified cancer screening and the Big Data
Arash Naeim, University of California, Los Angeles, Calif.

Concurrent Session 2: Behaviors That Keep Us Healthy
Session Chairperson: Kathleen Y. Wolin, Loyola University Chicago School of Medicine, Chicago, Ill.

Is it too late or too little? Prevention through physical activity
Kathleen Y. Wolin

Research on establishing policies for comprehensive UV protection
David Buller, Kelin Buendel, Inc., Golden, Colo.

Knowledge, attitudes, and uptake of breast cancer chemoprevention in a multi-ethnic cohort of high-risk women
Meghna S. Trivedi, Columbia University Medical Center, New York, N.Y.*

Quitting or switching? Health benefits and risk of electronic cigarettes
Maciej L. Goniewicz, Roswell Park Cancer Institute, Buffalo, N.Y.

Professional Advancement Session
Supported by Susan G. Komen®
11:45 a.m.-1:00 p.m.
Session Chairperson: Waun Ki Hong, The University of Texas MD Anderson Cancer Center, Houston, Texas

Box lunches will be provided.  Participation in this session is restricted to predoctoral or medical students and postdoctoral students or physicians-in-training. Click here for more information.

To preregister for this session, please click here.


Waun Ki Hong

Mary L. (Nora) Disis, University of Washington, Seattle, Wash.

Barnett S. Kramer, National Cancer Institute-DCP, Bethesda, Md.


Concurrent Sessions 3-4
1:00 p.m.-2:40 p.m.

Concurrent Session 3: Implementation Science
Session Chairperson: Jaye L. Viner, Curis, Inc., Lexington, Mass.

Dissemination and implementation of cancer prevention policies: The example of smoke-free public housing
Ann C. Klassen, Drexel University School of Public Health,  Philadelphia, Pa.

Incorporating patient reported data into clinical decision making: The example of rectal cancer surgery
Larissa K. F. Temple, Memorial Sloan Kettering Cancer Center, New York, N.Y. 

Improving decision-making for ductal carcinoma in situ
Rinaa S. Punglia, Harvard Medical School Center for Outcomes & Policy Research, Dana-Farber Cancer Institute, Boston, Mass.

Concurrent Session 4: Harnessing the Immune System for Cancer Prevention
Session Chairperson: Augusto C. Ochoa, Louisiana State University Health Sciences Center, New Orleans, La.

Augusto C. Ochoa

Multi-antigen vaccines for cancer prevention
Mary L. (Nora) Disis, University of Washington, Seattle, Wash.

High-priority immunotherapy agents in development to treat and prevent cancer
Martin A. (Mac) Cheever, Fred Hutchinson Cancer Center, Seattle, Wash.

Costimulation and coinhibition in preventing tumor progression
Lieping Chen, Yale University, New Haven, Conn.

Plasma 25-hydroxyvitamin D and risk of colorectal cancer according to lymphocytic reaction and tumor-infiltrating T-cell subsets 
Mingyang Song, Harvard School of Public Health, Boston, Mass.*

Concurrent Sessions 5-6
2:50 p.m.-4:30 p.m.

Concurrent Session 5: Combinatorial Approaches to Chemoprevention
Session Chairperson: Scott M. Lippman, UCSD Moores Cancer Center, La Jolla, Calif.

Targeting genetic drivers as an approach for combination chemoprevention
Scott M. Lippman

Exploiting aspirin's mechanism of action for combination chemoprevention
Andrew T. Chan, Massachusetts General Hospital, Boston, Mass.

Cooperation between a rexinoid and EGFR-TKI for lung cancer prevention via Cyclin D1 destabilization
Ethan Dmitrovsky, The University of Texas MD Anderson Cancer Center, Houston, Texas

Targeting multiple cell cycle regulatory points for the prevention of triple-negative breast cancer
Powel H. Brown, The University of Texas MD Anderson Cancer Center, Houston, Texas*


Concurrent Session 6: Screening Controversies: Breast, Lung, and Esophageal
Session Chairperson: Barnett S. Kramer, National Cancer Institute-DCP, Bethesda, Md.

Overview of cancer screening principles
Barnett S. Kramer

Breast cancer screening: Moving toward more informed decision making
Otis W. Brawley, American Cancer Society, Atlanta, Ga.

Lung cancer screening: From efficacy to effectiveness
Denise R. Aberle, David Geffen School of Medicine at
UCLA, Los Angeles, Calif.

Disease dynamics: Cancers evolving fast and slow or not at all
Brian J. Reid, Fred Hutchinson Cancer Research Center, Seattle, Wash.

Opening Plenary Session
6:00 p.m.-7:30 p.m.

Welcome and Opening Remarks
Phillip A. Dennis

A patient’s perspective on cancer and cancer prevention
Ralph R. Maggi, Lumasero Nano-Imaging Corporation, Midlothian, Va.

Report on the AACR Metformin Clinical Trials Workshop
Phillip A. Dennis

Distinguished Lecture on Targets for Cancer Prevention:
Targeting oncogenic alterations of metabolism
Chi Van Dang, Abramson Cancer Center of University of Pennsylvania, Philadelphia, Pa.

Opening Reception
7:30 p.m.-9:00 p.m.


*Short talks from proffered abstracts